Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biofrontera Inc 120 PRESIDENTIAL WAY SUITE 330 WOBURN MA 01801 USA

www.biofrontera.us.com P: 781-245-1325

Description:

Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera Inc. is based in WOBURN, MA.

Key Statistics

Overview:

Market Capitalization, $K 5,598
Enterprise Value, $K 8,158
Shares Outstanding, K 5,089
Annual Sales, $ 34,070 K
Annual Net Income, $ -20,130 K
Last Quarter Sales, $ 7,910 K
Last Quarter Net Income, $ -10,440 K
EBIT, $ -22,690 K
EBITDA, $ -21,630 K
60-Month Beta 0.65
% of Insider Shareholders 0.21%
% of Institutional Shareholders 10.08%
Float, K 5,079
% Float 99.79%
Short Volume Ratio 0.74

Growth:

1-Year Return -89.33%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.85 on 05/15/24
Next Earnings Date N/A
Earnings Per Share ttm -14.96
EPS Growth vs. Prev Qtr 20.60%
EPS Growth vs. Prev Year 57.95%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/05/23

BFRI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,390.99%
Return-on-Assets % -85.45%
Profit Margin % -59.08%
Debt/Equity -1.28
Price/Sales 0.16
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.36
Interest Coverage -41.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar